Forward Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Forward Management’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-20,000	Closed	-$1.51M	–	331
2015 Q2	$1.51M	Sell	20,000 -46,575	-70%	-$2.5M	0.09%	128
2015 Q1	$2.95M	Buy	66,575 +17,025	+34%	+$715K	0.18%	83
2014 Q4	$1.59M	Buy	49,550 +10,650	+27%	+$372K	0.09%	132
2014 Q3	$1.15M	Buy	38,900 +3,685	+10%	+$130K	0.07%	157
2014 Q2	$1.12M	Sell	35,215 -37,755	-52%	-$1.32M	0.06%	140
2014 Q1	$2.53M	Buy	72,970 +5,982	+9%	+$268K	0.15%	88
2013 Q4	$2.11M	Buy	66,988 +13,948	+26%	+$579K	0.13%	95
2013 Q3	$1.7M	Buy	53,040 +19,797	+60%	+$592K	0.11%	114
2013 Q2	$797K	Buy	+33,243	New	+$761K	0.07%	164

Other funds holding KYTH

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Forward Management's KYTH Position: Q3 2015 in Review

Forward Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q3 2015, closing a stake of 20,000 shares — an estimated $1.51M sold.

Forward Management first reported a position in KYTH in Q2 2013 and held it in 9 quarters. The position peaked at $2.95M in Q1 2015. 143 funds tracked by Wall St. Rank hold KYTH as of Q3 2015.

Forward Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q3 2015 after selling out during the quarter.
Forward Management sold 20,000 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q3 2015, an estimated $1.51M.
Forward Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 9 quarters.
Forward Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $2.95M in Q1 2015.
143 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q3 2015.

Based on Forward Management's 13F filing for Q3 2015, filed 9 Nov 2015.